Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Debt to Equity (2016 - 2026)

Mimedx's Debt to Equity history spans 12 years, with the latest figure at $0.07 for Q1 2026.

  • On a quarterly basis, Debt to Equity fell 21.29% to $0.07 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.07, a 21.29% decrease, with the full-year FY2025 number at $0.07, down 28.18% from a year prior.
  • Debt to Equity hit $0.07 in Q1 2026 for Mimedx, up from $0.07 in the prior quarter.
  • Over the last five years, Debt to Equity for MDXG hit a ceiling of $36.82 in Q3 2023 and a floor of -$6.49 in Q1 2022.
  • Historically, Debt to Equity has averaged $0.95 across 5 years, with a median of $0.08 in 2025.
  • Biggest five-year swings in Debt to Equity: tumbled 100.46% in 2022 and later skyrocketed 1582.54% in 2023.
  • Tracing MDXG's Debt to Equity over 5 years: stood at -$2.7 in 2022, then soared by 112.73% to $0.34 in 2023, then tumbled by 71.66% to $0.1 in 2024, then decreased by 28.18% to $0.07 in 2025, then increased by 3.41% to $0.07 in 2026.
  • Business Quant data shows Debt to Equity for MDXG at $0.07 in Q1 2026, $0.07 in Q4 2025, and $0.08 in Q3 2025.